Document is current
Any future updates will be listed below
-
Authors
Kusi, Kwadwo Asamoah
van der Puije, William
Asandem, Diana A.
Baba-Adam, Rawdat
Agbevey, Hardy
Asare, Bright
Segbefia, Philip
Bentum-Ennin, Lutterodt
Annan, Audrey
Osei, Frank
Teye-Adjei, Doreen
Galevo, Elsie Sutaya
Odame, Gifty
Ansa, Gloria
Amoah, Linda
Bonney, Joseph Humphrey Kofi
- License Information
-
More Information
Article History
Received: 3 October 2022
Accepted: 12 June 2023
First Online: 16 June 2023
Declarations
:
: The authors declare no competing interests.
: We were immensely supported by AngloGold Ashanti Limited, a global gold mining company. We also had funding support from the HEPMAL project – an European Commission EDCTP2-funded project based at the University of Ghana, the West African Centre for Cell Biology of Infectious Pathogens (WACCBIP), Inqaba Biotec West Africa Limited (IBWA) and Kingdom Books and Stationary (KBTS) Limited. We also received first and second dose series vaccines free of charge from Crescent Chemist Co. Limited, agents of Biotest Pharma of Germany and we are indeed grateful to them.
: This medical screening and vaccination exercise which was captured under the activities of the HEPMAL project was performed after obtaining an Institutional Review Board (IRB) approval from the Noguchi Memorial Institute for Medical Research IRB with the number, NMIMR-IRB CPN 046/19–20. Informed consent was obtained from participants and legal guardian(s), and all the steps were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
